January 13, 2022

OssDsign to Collect Data on Catalyst Bone Graft

OssDsign to Collect Data on Catalyst Bone Graft
OssDsign will launch a U.S. clinical registry to collect real-world data on Catalyst in spinal fusion applications.
December 14, 2021

Avanos Medical To Acquire OrthogenRx

Avanos Medical To Acquire OrthogenRx
OrthogenRx has developed GenVisc and TriVisc viscosupplementation products to treat OA knee pain.
November 29, 2021

Bone Therapeutics Partners on Global ALLOB Rights

Bone Therapeutics Partners on Global ALLOB Rights
Link Health will have global rights for development, manufacturing and commercialization of ALLOB allogeneic bone cell therapy.
November 9, 2021

Graftys Acquires Biologics4Life

Graftys Acquires Biologics4Life
Biologics4Life is developing a injectable synthetic bone graft materials, complementing Graftys' resorbable calcium phosphate cement.
October 29, 2021

Bioventus Completes the Acquisition of Misonix

Bioventus Completes the Acquisition of Misonix
The combined company will operate as a pure-play regenerative medicine and orthopedics company, serving hospital, ASC and office care settings.

M&A | Partnerships

December 14, 2021

Avanos Medical To Acquire OrthogenRx

Avanos Medical To Acquire OrthogenRx
OrthogenRx has developed GenVisc and TriVisc viscosupplementation products to treat OA knee pain.

Products

January 13, 2022

OssDsign to Collect Data on Catalyst Bone Graft

OssDsign to Collect Data on Catalyst Bone Graft
OssDsign will launch a U.S. clinical registry to collect real-world data on Catalyst in spinal fusion applications.

Regulatory